1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
- 2015
- Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.
- Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma.
- 2014
- GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics
-
A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
Walther, Charles LU ; Tayebwa, Johnbosco LU ; Lilljebjörn, Henrik LU
; Magnusson, Linda
LU
; Nilsson, Jenny
LU
; Vult von Steyern, Fredrik
LU
; Øra, Ingrid
LU
; Domanski, Henryk
LU
; Fioretos, Thoas
LU
and Hansén Nord, Karolin
LU
, et al.
(2014)
In Journal of Pathology
232(5).
p.534-540
Mark
- 2013
- WHO Classification of Tumours of Soft Tissue and Bone : WHO Classification of Tumours, vol. 5
- 2012
- MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association With FUS Gene Rearrangement.
- Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
- Recurrent Rearrangement of the PHF1 Gene in Ossifying Fibromyxoid Tumors.